Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.88
2.19
NAV
₹537.87
₹40.96
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹4323.29 Cr
₹6668.95 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
1 Year
10.58%
5.68%
3 Year
25.13%
26.25%
5 Year
15.50%
15.27%
Equity
97.38%
96.76%
Cash
2.55%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 6.77% |
Acutaas Chemicals Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.30% |
Max Healthcare Institute Ltd. | 5.17% |
Aster DM Healthcare Ltd. | 3.89% |
Lupin Ltd. | 3.84% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Anthem Biosciences Ltd. | 3.45% |
Aether Industries Ltd. | 3.35% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018
